跳至主要内容
临床试验/NCT07763353
NCT07763353尚未招募不适用

Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart Failure

Chung Shan Medical University0 个研究点目标入组 27 人开始时间: 2026年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
27
主要终点
Heart Rate Variability

研究概览

简要总结

Background:

Heart failure (HF) is a major global public health concern characterized by impaired cardiac function, high mortality, frequent hospital readmissions, and substantial healthcare burden. Autonomic nervous system (ANS) dysfunction plays a critical role in the pathophysiology of HF, typically presenting as increased sympathetic activity and reduced parasympathetic activity. Heart rate variability (HRV), a non-invasive marker of cardiac autonomic regulation, has been widely used to evaluate autonomic function and predict clinical outcomes in patients with HF. Reduced HRV is associated with increased risks of sudden cardiac death, cardiovascular events, and hospital readmission. Although cardiac rehabilitation (CR) has been demonstrated to improve exercise capacity, quality of life, and clinical outcomes in HF patients, its effects on autonomic modulation, particularly during Phase I cardiac rehabilitation, remain insufficiently investigated.

Slow-paced breathing (SPB) has emerged as a potential non-pharmacological intervention for enhancing autonomic regulation. By synchronizing respiratory rhythm with cardiovascular oscillations, SPB may enhance baroreflex sensitivity, increase vagal activity, and improve HRV. Previous studies have suggested beneficial effects of SPB on autonomic function; however, the findings remain inconsistent, and evidence regarding its short-term effects on HRV among hospitalized HF patients undergoing early cardiac rehabilitation is limited. Therefore, further investigation is warranted to determine whether SPB can provide additional autonomic benefits when incorporated into Phase I cardiac rehabilitation.

Objective:

This study aims to investigate the effects of slow-paced breathing combined with Phase I cardiac rehabilitation on autonomic nervous system function in patients with heart failure, using HRV as the primary outcome measure.

Methods:

This study will employ a parallel randomized controlled trial design. Hospitalized patients diagnosed with heart failure will be randomly allocated into either the SPB intervention group or the control group. Both groups will receive standard Phase I cardiac rehabilitation, while the intervention group will additionally receive slow-paced breathing training. The primary outcomes will include changes in HRV parameters, including time-domain indices (standard deviation of NN intervals [SDNN] and root mean square of successive differences [RMSSD]) and frequency-domain indices (low-frequency power [LF], high-frequency power [HF], and LF/HF ratio), to evaluate changes in cardiac autonomic regulation before and after intervention.

详细描述

Physiological Link Between Slow-Paced Breathing and Autonomic Nervous System Regulation

Although conventional breathing exercises (e.g., diaphragmatic breathing and deep breathing) facilitate lung expansion, prevent premature alveolar and airway collapse, and maintain normal respiratory function and adequate gas exchange, these techniques primarily focus on the quantity of breathing and respiratory muscle activity. In contrast, slow-paced breathing (SPB) is a controlled breathing technique that primarily regulates the breathing frequency and maintains a fixed inspiratory-to-expiratory ratio, allowing synchronization with intrinsic cardiovascular oscillations to enhance cardiopulmonary function and autonomic regulation. Slow-paced breathing, also referred to as slow breathing, resonance frequency breathing, or paced breathing, is considered a method that influences autonomic nervous system (ANS) function through modulation of respiratory frequency.

The interaction between respiration and cardiovascular regulation is mediated through the autonomic nervous system, which regulates heart rate, blood pressure, and respiratory patterns. This physiological coupling is known as respiratory sinus arrhythmia (RSA), which is considered one of the primary contributors to HRV. Under normal RSA conditions, heart rate slightly increases during inspiration and decreases during expiration. This phenomenon reflects parasympathetic modulation of cardiac activity and serves as an important physiological indicator of vagal function.

The interaction between respiratory and cardiovascular systems involves three major components: the respiratory network, the cardiovascular network, and their central synaptic interactions. The respiratory network within the central nervous system generates respiratory commands that activate respiratory motor neurons, leading to respiratory muscle activity. During this process, two major types of afferent feedback signals are generated from the lungs: chemical feedback and mechanical feedback. Chemical feedback is mediated through the aortic arch and carotid bodies, which detect changes in oxygen, carbon dioxide, and hydrogen ion concentrations and transmit these signals back to the brain. Mechanical feedback occurs through lung expansion during inspiration, which activates lung stretch receptors; meanwhile, respiratory-induced changes in intrathoracic pressure also generate afferent signals transmitted to the central nervous system.

Meanwhile, the cardiovascular network regulates cardiac activity and vascular smooth muscle function through the autonomic nervous system, resulting in changes in heart rate and vascular resistance. The vascular system determines systolic arterial pressure (SAP) and diastolic arterial pressure (DAP), leading to alterations in blood pressure and arterial blood conditions. Changes in blood pressure stimulate baroreceptors located in the aortic arch and carotid sinus, which subsequently transmit sensory information back to the brain. Ultimately, these signals are integrated within the nucleus tractus solitarius (NTS) in the brainstem, resulting in respiratory-mediated modulation of cardiovascular autonomic control

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with heart failure during hospitalization and who are clinically stable.

排除标准

  • Respiratory distress at rest with the utilization of accessory neck muscles (neck breathing pattern).
  • Presence of an implanted cardiac pacemaker. Chronic pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, pulmonary fibrosis, or exercise-induced asthma.
  • Current use of mechanical ventilation. Severe aortic stenosis. Aortic dissection. Acute myocarditis, pericarditis, or infective endocarditis. Inability to walk independently due to orthopedic, neurological, or other medical conditions.
  • Inability to understand the study protocols or cooperate, such as individuals with psychiatric disorders, dementia, or a history of stroke.

研究组 & 干预措施

Slow-paced breathing

Experimental

干预措施: Slow-paced breathing intervention (Other)

Usual Breathing

Placebo Comparator

干预措施: Placebo (Other)

结局指标

主要结局

Heart Rate Variability

时间窗: 20 mins/session, 2 sessions/day, for 8 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chung Shan Medical University Hospital

Assistant Professor

Chung Shan Medical University

相似试验